Mattias Levin (Former)
1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
- 2021
-
Mark
Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy
(
- Contribution to journal › Article
- 2017
-
Mark
Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE
(
- Contribution to journal › Letter
- 2016
-
Mark
Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy.
(
- Contribution to journal › Article
- 2015
-
Mark
A folded and immunogenic IgE-hyporeactive variant of the major allergen Phl p 1 produced in Escherichia coli.
(
- Contribution to journal › Article
-
Mark
A microarray-based reaction rate analysis platform. Is there evidence of validity?
(
- Contribution to journal › Letter
- 2014
-
Mark
Human IgE against the major allergen Bet v 1 - defining an epitope with limited cross-reactivity between different PR-10 family proteins.
(
- Contribution to journal › Article
-
Mark
Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.
(
- Contribution to journal › Article
-
Mark
The human IgE repertoire
(
- Contribution to journal › Scientific review
-
Mark
Next Generation Sequencing and antibody engineering in combination defines different fates of allergen-specific antibodies during specific immunotherapy
2014) European Academy of Allergy and Clinical Immunology Congress 2014(
- Contribution to conference › Abstract